Efficiency of vitrectomy in diabetic macular edema and morphometry of surgically removed of the internal limiting membrane;Význam vitrektomie u diabetického makulárního edému a morfometrie chirurgicky odstraněné vnitřní limitující membrány

Ceska a Slovenska Oftalmologie

Volumn 66, Issue 2, 2010, Pages 76-82

  Kalvoda, J ^a,b   Duskova J ^a   Kovarik Z ^a   Kubena A ^a   Kalvodova B ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Diabetic macular edema; Glykosylated hemoglobin; Internal limiting membrane; Morphometry; Vitrectomy

Indexed keywords

DIABETIC RETINOPATHY; EYE SURGERY; FEMALE; HUMAN; MACULAR EDEMA; MALE; MIDDLE AGED; PROCEDURES; VITRECTOMY;

DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; VITRECTOMY;

EID: 77955934899     PISSN: 12119059     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Avci, P., Kaderll, B., Avci, B. et al.: Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema. Graefe's Arch. Exp.Ophthalmol., 2004, 242: 845-852.
2. Bran, A.J., Tripathi, R.C., Trlpathi, B.J.: The inner limiting membrane. In Wolff's anatomy of the eye, Chapman & Hall, 1997, 488 p.
3. Dilllnger, P., Mester, U.: Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular edema. Graefe's Arch. Clin. Exp. Ophthalmol., 2004, 242:630-637.
4. Do, D.V., Shah, S.M., Sung, J.U. et al.: Persistent diabetic macular edema is associated with elevated Hemoglobin A1c. Am. J. Ophthalmol., 2005, 139: 620-623.
5. Dol, N., Uemura, A., Nakao, K. et al.: Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy. Retina, 2005, 25:742-745.
6. Ducournau, D., Ducournau, Y.: A Closer Look at the ILM. Removal of the ILM induces a cellular response that allows the retina to fight against edema. A Supplement to Retinal Physician, 2008, July/August: 4-15.
7. Flgueroa, M.S., Contreras, I., Noval, S.: Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. Retina, 2008, 28:420-428.
8. Foss, R.I.: Vitreoretinal juncture: topographical variations. Invest. Ophthalmol., 1972, 11:801-808.
9. Gandorfer, A., Messmer, E.M., Ulbig, M.W. et al.: Resolution of diabetic macular edema after surgical removal of the posterior hyaloids and the inner limiting membrane. Retina, 2000, 20: 126-133.
10. Hartley, K.L., Smiddy, W., Flynn, J.R.H. et al.: Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina, 2008, 28:410-419.
11. Ikeda, T., Sato, K., Katano, T. et al.: Vitrectomy for cystoid macular oedema with attached posterior hyaloid membrane in patients with diabetes. Br. J. Ophthalmol., 1999, 83:12-14. (Pubitemid 29106323)
12. Joussen, A.M., Naumann, G.O., Coupland, S.E. et al.: Retina and Vitreous. In Neumann, G.O., Holbach, L, Kruse, F.E. et al. Applied pathology for ophthalmic microsurgeons. Springer, Berlin Heidelberg New York, 2008, pp 306-307.
13. Kalvodová, B., Záhlava, J.: Results of vitrectomy in cystoid diabetic macular edema detected by optical coherence tomography. Čes. a slov. Oftal., 2002, 58: 224-232.
14. Klmura, T., Kiryu, J., Nishiwakl, H. et at.: Efficacy of surgical removal of the internal limiting membrane in diabetic cystoid macular edema. Retina, 2005, 25:454-461.
15. Kojima, T., Terasami, H., Nomura, H. et al.: Vitrectomy for diabetic macular edema: effect of glycemic control (HbA1c), renal function (creatinine) and other local factors. Ophthalmic Res., 2003, 35: 192-198.
16. Kuhn, F., Kiss, G., Mester, V. et al.: Vitrectomy with internal limiting membrane removal for clinically significant macular oedema. Graefe's Arch. Exp. Ophthalmol., 2004, 242: 402-408.
17. Kumagai, K., Furukawa, M., Oglno, N. et al.: Vitreous surgery with and without internal limiting membrane peeling for macular hole repair. Retina, 2004, 24:721-727.
18. La Heij, E.C., Dleudonné, S.C., Mooy, CM. et al.: Immunohistochemical analysis of the internal limiting membrane peeled with indocyanine green. Am. J. Ophthalmol., 2005, 140: 1123-1125.
19. Lewis, H., Abrams, G.W., Blumenkranz, M.S. et al.: Vitrectomy for diabetic macular traction and edema associated with posterior hyaloids traction. Ophthalmology, 1999, 99:753-759.
20. Matsunaga, N., Ozekl, H., Hlrabayashi.Y. et al.: Histopathologic evaluation of the limiting membrane surgically excised from eyes with diabetic maculopathy. Retina, 2005, 25:311-316.
21. Patel, J.I., Hykin, P.G., Schadt, M., et al.: Pars plana vitrectomy with and without peeling of the inner limiting membrane for diabetic macular edema. Retina, 2008, 26:5-13.
22. Pendergast, S., Margherlo, R., Williams, G. et al.: Vitrectomy for chronic pseudophakic cystoid macular edema. Am. J. Ophthalmol., 1999, 128:317-323.
23. Peyman, G.A., Cheema, R,. Conway, M.D. et al.: Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloids during pars plana vitrectomy. Retina, 2000,20: 54-555.
24. Sakamoto, T., Mlyazaki, M., Hisatoml, T, et al.: Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefe's Arch. Exp. Ophthalmol., 2002, 240:423-429.
25. Sebag J.: Age-related differences in the human vitreoretinal interface. Arch. Ophthalmol., 1991,109:966-971.
26. Sonoda, K.H., Sakamoto, T., Enaida, H. et al.: Residual vitreous separation visualized by intravitreous triamcinolone acetonide. Ophthalmology, 2004, 111: 226-230.
27. Stefaniotou, M., Aspiotis, M., Kalogeropoulos, C. et al.: Vitrectomy results for diffuse diabetic macular edema with and without inner limiting membrane removal. Eur. J. Ophthalmol., 2004, 14:137-143.
28. Tachi N, Ogino N.: Vitrectomy for diffuse macular edema in cases of diabetic retinopathy. Am. J. Ophthalmol., 1996, 122: 258-260. (Pubitemid 26271437)
29. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes. N. Engl. J. Med., 1993, 329: 977-986.
30. United Kingdom Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes. UKPDS 38. Br. Med. J., 1998, 317:703-713.